» Articles » PMID: 22924717

Hemodynamic Effects in Dogs After Intramuscular Administration of a Combination of Dexmedetomidine-butorphanol-tiletamine-zolazepam or Dexmedetomidine-butorphanol-ketamine

Overview
Journal Am J Vet Res
Date 2012 Aug 29
PMID 22924717
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate hemodynamic effects in dogs after IM administration of dexmedetomidine (7.5 μg/kg, butorphanol (0.15 mg/kg), and tiletamine-zolazepam (3 mg/kg [DBTZ]) or dexmedetomidine (15 μg/kg), butorphanol (0.3 mg/kg), and ketamine (3 mg/kg [DBK]).

Animals: 5 healthy adult mixed-breed dogs.

Procedures: Each dog received DBTZ and DBK in a randomized crossover study with a 48-hour interval between treatments. Anesthesia was induced and maintained with sevoflurane in 100% oxygen while instrumentation with Swan-Ganz and arterial catheters was performed. Following instrumentation, hemodynamic measurements were recorded at 3.54% (1.5 times the minimum alveolar concentration) sevoflurane; then sevoflurane administration was discontinued, and dogs were allowed to recover. Six hours after cessation of sevoflurane administration, baseline hemodynamic measurements were recorded, each dog was given an IM injection of DBTZ or DBK, and hemodynamic measurements were obtained at predetermined intervals for 70 minutes.

Results: DBTZ and DBK induced hypoventilation (Paco2, approx 60 to 70 mm Hg), respiratory acidosis (pH, approx 7.2), hypertension (mean arterial blood pressure, approx 115 to 174 mm Hg), increases in systemic vascular resistance, and reflex bradycardia. Cardiac output, oxygen delivery, and oxygen consumption following DBTZ or DBK administration were similar to those following sevoflurane administration to achieve a surgical plane of anesthesia. Blood l-lactate concentrations remained within the reference range at all times for all protocols.

Conclusions And Clinical Relevance: In healthy dogs, both DBTZ and DBK maintained oxygen delivery and oxygen consumption to tissues and blood lactate concentrations within the reference range. However, ventilation should be carefully monitored and assisted when necessary to prevent hypoventilation.

Citing Articles

Retrospective Comparison of the Anesthetic Effects of Tiletamine-Zolazepam with Dexmedetomidine and Ketamine with Dexmedetomidine in Captive Formosan Serow ().

Chang L, Weng H, Lien C, Chen K Animals (Basel). 2024; 14(10).

PMID: 38791631 PMC: 11117321. DOI: 10.3390/ani14101413.


The Effect of a Subsequent Dose of Dexmedetomidine or Other Sedatives following an Initial Dose of Dexmedetomidine on Sedation and Quality of Recovery in Cats: Part I.

Margeti C, Kazakos G, Skampardonis V, Galatos A, Zacharopoulou T, Tsioli V Vet Sci. 2024; 11(5).

PMID: 38787158 PMC: 11126131. DOI: 10.3390/vetsci11050186.


Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method.

Imboden T, Pownall W, Rubin S, Spadavecchia C, Schollhorn B, Rohrbach H Acta Vet Scand. 2023; 65(1):41.

PMID: 37737188 PMC: 10515426. DOI: 10.1186/s13028-023-00697-8.


Intraocular pressure and cardiovascular effects of dexmedetomidine premedication and tiletamine-zolazepam for anesthetic induction in dogs.

Kusolphat P, Soimala T, Sunghan J Vet World. 2023; 15(12):2929-2936.

PMID: 36718325 PMC: 9880827. DOI: 10.14202/vetworld.2022.2929-2936.


Reduction of greenhouse gases emission through the use of tiletamine and zolazepam.

Lachowska S, Antonczyk A, Tunikowska J, Godniak M, Kielbowicz Z Sci Rep. 2022; 12(1):9508.

PMID: 35681078 PMC: 9184519. DOI: 10.1038/s41598-022-13520-7.